Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells

Leukemia

Volumn 10, Issue 2, 1996, Pages 238-248

  Rosnet, O ^a   Buhring H J ^b   Marchetto, S ^a   Rappold, I ^b,c   Lavagna, C ^a   Sainty, D ^d   Arnoulet, C ^d   Chabannon, C ^d   Kanz, L ^b   Hannum, C ^e   Birnbaum, D ^a  

^a INSERM   (France)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c SUGEN INC   (United States)

^d INSTITUT PAOLI CALMETTES   (France)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Flow cytometry; FLT3; Hematopoiesis; Leukemia; Monoclonal antibody

Indexed keywords

CD34 ANTIGEN; CELL SURFACE RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; STEM CELL FACTOR;

ACUTE LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BLAST CELL; BONE MARROW CELL; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 9244260192     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Uchida N, Fleming W, Alpern E, Weissman I. Heterogeneity of hematopoietic stem cells. Curr Opin Immunol 1993, 5: 177-184.
2. Metcalf D. Hematopoietic regulators: redundancy or subtlety. Blood 1993, 82: 3515-3523.
3. Ogawa M. Differentiation and proliferation of hematopoietic stem cells Blood 1993; 81: 2844-2853.
4. Moore M, Phil D, Shapiro F. Regulation and function of hematopoietic stem cells. Curr Opin Hematol 1994; 1: 180-186.
5. Morrison S, Weissman I. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994; 1: 661-673.
6. Sherr C et al. The c-fms proto-oncogene product is related to the receptor for mononuclear phagocyte growth factor, CSF-1. Cell 1985, 41: 665-676.
7. Morrison-Graham K, Takahashi Y. Steel factor and c-kit receptor: from mutants to a growth factor system. Bioessays 1993; 15: 77-83.
8. Lev S, Blechman J, Givol D, Yarden Y. Steel factor and c-kit pro-tooncogene: genetic lessons in signal transduction. Crit Rev Oncogen 1995; 5: 141-168.
9. McNiece I, Langlev K, Zsebo K. The role of recombinant stem cell factor in early B cell development. J Immunol 1991; 146: 3785-3790.
10. Williams D et al. The steel factor. Develop Biol 1992; 151: 368-376.
11. Rolink A, Streb M, Nishikawa SI, Melchers F. The c-kit-encoded tyrosine kinase regulates the proliferation of early pre-B cells. Eur J Immunol 1991; 21: 2609-2612.
12. Faust E et al. Distinctive growth requirement and genes expression patterns distinguish progenitor B cells from pre-B cells. J Exp Med 1993; 177: 915-923.
13. Okada S et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991; 78: 1706-1712.
14. Orlic D et al. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptors. Blood 1993; 82: 762-770.
15. Ikuta K, Wetssman I. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their regeneration. Proc Natl Acad Sci USA 1992; 89: 1502-1506.
16. Li CL, Johnson GR. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 1994; 84: 408-414.
17. Matthews W et al. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65: 1143-1152.
18. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994; 91: 459-463.
19. Lyman S et al. Molecular cloning of a ligand for the flt3/flk2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157-1167.
20. Lyman S et al. Cloning of the human homolog of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795-2801.
21. Muench M et al. FLK-2/FLT3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 1995; 85: 963-972.
22. Hannum C et al Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of hematopoietic stem cells and is encoded by variant RNAs. Nature 1994; 368: 643-648.
23. Hirayama F, Lyman S, Clark S, Ogawa M. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early-B lymphoid progenitors. Stood 1995; 85: 1762-1768.
24. Lyman S, Brasel K, Rousseau A, Williams D. The FLT3 ligand - a hematopoietic stem cell factor whose activities are distinct from steel factor. Stem cells 1995; 12: (Suppl. 1): 99-110.
25. Zeigler F et al. Cellular and molecular characterization of the role of the FLK-2/FLT3 receptor tyrosine kinase in hematopoietic stem cells. Blood 1994; 84: 2422-2430.
26. Bennett J et al. Proposed revised criteria for the classification of acute myetoid leukemias. Ann Intern Med 1985; 103: 620-625.
27. Lavagna C, Marchetto S, Birnbaum D, Rosnet O. Identification and characterization of a functional murine FLT3 isoform produced by exon skipping. J Biol Chem 1995; 270: 3165-3171.
28. c-kit) summary report (CD117). In: Schlossman S et al (eds). Leucocyte Typing V. Oxford University Press: Oxford, 1995.
29. c-kit function in cells of patients with acute myeloblastic leukemia. Cancer Res 1993; 53: 4424-4431.
30. Maroc N et al Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene 1993; 8: 909-918.
31. Wang C et al. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia 1991; 5: 493-499.
32. Koistinen P et al. OCI/AML-4 anacute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Leukemia 1991; 5: 704-711.
33. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-212.
34. Ashman L et al. Epitope mapping and functional studies with three monoclonal antibodies to the C-KIT receptor tyrosine kinase, YB5.B8, 17F11, and SR-1. J Cell Physiol 1994; 158: 545-554.
35. Birg F et al. Expression of the FMS/KIT like gene FLT3 in acute leukemias of the myeloid and lymphoid lineages. Blood 1992; 80: 2584-2593.
36. Rosnet O et al. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 82: 1110-1119.
37. DaSilva N et al. Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia 1994; 8: 885-888.
38. Meierhoff G et al. Expression of the FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995; 9: 1368-1372.
39. Hu Z-B et al. c-kit expression in human megacaryoblastic cell lines. Blood 1994; 83: 2133-2144.
40. + cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow. J Exp Med 1992; 175: 1501-1509.
41. deLapeyrière O et al. Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues. Differentiation 1995; 58: 351-359.
42. Moore M et al. Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells. Blood 1980; 55: 682-692.
43. Keating A, Powell J, Takahashi M, Singer J. The generation of human long-term marrow cultures from bone marrow depleted of Ia (HLA-DR) positive cells. Blood 1984; 64: 1159-1162.
44. Strobl H et al. Antigenic analysis of human haematopoietic progenitor cells expressing the growth factor receptor c-kit. Br J Haematol 1992; 82: 287-294.
45. Briddell R et al. Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 1992; 79: 3159-3167.
46. + bone marrow cells. Blood 1994; 84: 1473-1481.
47. DiGiusto D et al. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994; 84; 421-432.
48. Katayama N et al. Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 1993; 82: 2353-2360.
49. high cells. Blood 1993; 82: 3283-3289.
50. Ashman L et al. Expression of the YB5.B8 antigen (c-kit protooncogene product) in normal human bone marrow. Blood 1991; 78: 30-37.
51. Macedo A et al. Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML. Br J Haematol 1995; 89: 338-341.
52. Yamaguchi Y et al. Expression of the c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells. Exp Hematol 1993; 21: 1233-1238.
53. Uckun F et al. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995; 267: 886-891.